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THE JOURNAL OF BIOLOGICAL CHEMISTRY 
Vol. 251, No. 19, Issue of October 10, pp. 6016-6024, 1976 
Prmted in U.S.A. 
Effect of Glycosylation on the in Vivo Circulating Half-life of 
Ribonuclease * 
(Received for publication, June 10, 1976) 
JOHN W. BAYNES$ AND FINN WOLD§ 
From the Department of Laboratory Medicine and Pathology, School of Medicine, and the Department of 
Biochemistry, College of Biological Sciences, University of Minnesota, St. Paul, Minnesota 55108 
The circulating half-lives of the four isozymes of bovine pancreatic ribonuclease (RNases A, B, C, and 
D) have been determined in normal and in nephrectomized rats. The isozymes differ only in their glycosyl 
content. While A contains no sugars, B has a simple oligosaccharide (GlcNAc, Man,+), and C and D each 
have a complex oligosaccharide (GlcNAc, Man,., Gal, Fuc NeuAc%, and GlcNAc, Mans Gal, Fuc 
NeuAc,, respectively) attached to Asn-34 of the polypeptide chain. All four isozymes were cleared rapidly 
in normal rats (t,,, = 2 to 3 min), as expected on the basis of the established role of the kidneys in 
removing low molecular weight proteins from circulation. In nephrectomized rats, however, a much 
slower clearance was observed, thus permitting the evaluation of the role of the carbohydrate chains in 
the catabolism of the isozymes. The clearance curves can be analyzed in terms of two processes, a rapid 
initial one, shown to represent the equilibration of the injected enzyme into extravascular space, and a 
second one which is interpreted as the catabolic clearance of the enzyme. The half-life of the RNase 
isozymes was calculated from this second process and found to be in the range 528 to 577 min for RNase 
A, 15 min for RNase B, 681 to 862 min for RNase C, and 839 to 941 min for RNase D. The rapidly cleared 
RNase B was treated with cu-mannosidase to remove 3 of the 4 mannosyl residues, leaving only a 
trisaccharide (GlcNAc,-PMan) attached to the protein. The half-life of this RNase B derivative was 
found to be in the range 616 to 733 min. From these results it is concluded (a) that the addition of complex 
oligosaccharides to a protein does not have any significant direct effect on its circulating half-life (RNases 
C and D compared to RNase A), and (b) that in the rat there exists a mechanism for clearing 
glycoproteins based on specific recognition of exposed oc-mannosyl residues (RNase B compared to the 
other isozymes and to cY-mannosidase-treated RNase B). 
t 
The physiological sites and mechanisms involved in the 
homeostatic regulation of plasma protein turnover are as yet 
poorly understood. The role of prosthetic oligosaccharides as 
regulatory determinants for the catabolism of circulating 
glycoproteins has received much attention, however, since the 
pioneering investigations of Ashwell, Morell, and co-workers 
(2); They demonstrated that in vitro modifications of the 
oligosaccharides of several plasma glycoproteins can produce 
significant alterations in their circulating half-life, and have 
described a mechanism for the rapid hepatic catabolism of 
plasma asialo-(P-galactoside terminal)glycoproteins. More 
recent reports have indicated (3-5) that further degradation of 
plasma protein oligosaccharides, resulting in exposure of 
*This work was supported by United States Public Health Service 
Training Grant GM 00345 and Research Grant GM 15053 from the 
National Institutes of Health. The work is included in a thesis 
submitted by J. W. B. in partial fulfillment of the requirements for the 
M.S. Degree in Laboratory Medicine. A preliminary report of the 
results has been uresented (1). 
$ Recipient of American Cancer Society Postdoctoral Fellowship 
PF-1147. Present address, Department of Chemistrv. Universitv of 
South Carolina, Columbia, So;th Carolina 29208. ” 
8To whom correspondence should be directed at Department of 
Biochemistry, University of Minnesota, St. Paul, Minnesota 55108. 
internal /3-N-acetylglucosaminyl and core cu-mannosyl resi- 
dues, might also trigger the rapid clearance of these glyco- 
proteins from the circulation. However, the extent to which 
these carbohydrate-specific clearance processes are involved in 
the in uiuo regulation of plasma glycoprotein metabolsim is 
still unclear. 
While the previous studies have focused on the effects of 
partially degraded oligosaccharides on the catabolism of glyco- 
proteins, the goal of the present study was to assess the overall 
effect of the complete, native oligosaccharide component on 
glycoprotein metabolism. To achieve this goal we required a 
system in which the specific contribution of the oligosaccharide 
prosthetic group and the apoprotein component could be 
separately evaluated. Fortunately, nature has provided such 
a system, in the form of the four bovine pancreatic ribonuclease 
(RNase) isozymes. These isozymes, described by Plummer and 
Hirs (6, 7), consist of the same polypeptide chain, and differ 
only in their degree of glycosylation at asparagine residue 34: 
RNase’ A is the unglycosylated “aglycone”; RNase B has the 
‘The abbreviations used are: RNase. bovine pancreatic ribonu- 
clease; DFP, diisopropyl phosphorofluoridate;- Con A-agarose, 
insolubilized. aparose-bound concanavalin A; RNase B”, RNase B 
isozyme specifically prepared from commercial RNase B (Sigma type 
6016 
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Circulating Ijalf-life of RNases A, B, C, and D 
characteristic, simple plasma-type oligosaccharide side chain 
containing only mannose and N-acetylglucosamine; RNases C 
and D have complex plasma-type oligosaccharides containing 
galactose, fucose, and sialic acid, as well as mannose and 
N-acetylglucosamine. These isozymes of RNase are identical in 
amino acid composition, ultraviolet absorption spectra, and 
specific enzymatic activity, with tryptic peptide maps indicat- 
ing that they have identical amino acid sequences (8). Thus, 
comparing the in uiuo plasma half-lives of the various glycopro- 
tein isozymes of RNase to the half-life of the aglycone RNase A 
it is possible to evaluate directly the effect of glycosylation on 
the plasma survival time of a polypeptide chain. 
MATERIALS AND METHODS 
Enzyme Assays-RNase activity was determined using either cyti- 
dine 2’:3’-phosphate (9) or yeast RNA as substrate. Assays using RNA 
substrate were performed by a modification of the procedure of 
Anfinsen et al. (10). RNase (0 to 100 ng) was added to 0.05 ml of 0.1 M 
Tris.HCl, pH 7.4, which contained 1 M NaCl, and 0.2 mg/ml of bovine 
serum albumin to prevent adsorption of the enzyme on glass. The 
reaction was started by addition of 1 ml of 8 mg/ml of RNA in 0.1 M 
Tris.HCl, pH 7.4, incubated for 20 min at room temperature, and 
stopped by addition of 1 ml of 1.25% many1 acetate in 12.5% 
trichloroacetic acid. Following centrifugation, 0.5 ml of supernatant 
was diluted to 2.5 ml with water, and the absorbance at 260 nm was 
determined. RNase A (Sigma, type lA), purified by ion exchange on 
IRC-50 according to Hirs et al. (ll), was used as the standard for 
estimation of RNase concentration. 
Protein and Amino Acid Determinations-Protein concentration 
during RNase purification was estimated from absorbancy measure- 
ments, using an absorbance (280 nm) of 18 for a 1% solution of 
unfractionated pancreatic juice (12). Protein concentration in the 
purified RNase isozyme preparations was determined from amino acid 
analyses. Amino acid analyses were performed on the Beckman model 
119 amino acid analyzer. Samples were adjusted to approximately 0.5 
mg of protein/ml of 6 N HCl, and hydrolyzed in evacuated, sealed 
ampoules for 24 h at 110”. 
Carbohydrate Analyses of RNase Isozynes-Neutral sugars were 
estimated on a Technicon carbohydrate analyzer according to Lee et 
al. (13, 14), following hydrolysis of 0.5 mg of protein/ml of 2 N 
trifluoroacetic acid for 4 h at 100”. Glucosamine was estimated with 
the amino acid analyzer following hydrolysis of 0.5 mg/ml of 3 N HCl 
for 9 h at 110”. Corrections for destruction of carbohydrates during 
hydrolysis were estimated from hydrolyses of known amounts of 
monosaccharides in the presence of RNase A. Sialic acid was deter- 
mined by the thiobarbituric acid method of Warren (15) following 
hydrolysis of protein in 0.1 N H,SO, for 1 h at 80”. 
Disc Gel Electrophoresis-Electrophoresis of RNase isozymes was 
carried out at pH 4.0, in 15% cross-linked polyacrylamide gels for 6 h at 
5 mA per gel according to McAllister et al. (16). 
Purification of RNase Isozymes-Bovine pancreatic juice was 
obtained by pancreatic duct cannulation,’ according to the method of 
Wass (17). Secretions were collected in iced containers changed at 12-h 
intervals, DFP (1 M in isopropanol) was added to a final concentration 
of 5 x lo-’ M, and the juice was lyophilized. The resulting powder was 
stored at -20”. RNase activity was found to be stable for at least 3 
months under these conditions. All purification steps were carried out 
at 4’. 
The lyophilized pancreatic juice powder was dissolved with stirring 
in distilled water (lo%, w/v), and DFP was added to 1 mM final 
concentration. The solution was dialyzed in a Bio-Rad Bio-Fiber-50 
beaker against 0.2 M sodium acetate buffer, pH 5.2, until chloride ion 
was no longer detectable in the dialysate by titration with 0.1 M 
AgNO,. Precipitated protein was removed by centrifugation for 10 min 
at 12,000 x g. If necessary, the pH was adjusted to pH 5.2 with a few 
XII-B); RNase B’, the product of cu-mannosidase digestion of RNase 
B’. 
*The authors wish to express their appreciation to Dr. D. E. Otterby 
and Mr. S. A. Nelson, of the Department of Animal Science, 
University of Minnesota for donating and caring for the animals used 
in this study, and to Dr. E. A. Usenik, Department of Surgery, 
University of Minnesota School of Veterinary Medicine, for performing 
the pancreatic duct cannulations. 
FIG. 1. Chromatography of pancreatic juice on RNase affinity 
column. Lyophilized pancreatic juice powder (16 g total weight, 6 g of 
protein), containing 170 mg of RNase activity in 280 ml of 0.2 M 
sodium acetate, pH 5.2, was chromatographed on a 40-ml (2 x 13 cm) 
RNase affinity column. Elution with 4 M NaCl resulted in recovery of 
168 mg of RNase, with Il-fold purification. Fraction volume: 7 to 8 ml. 
drops of 1 M acetic acid. This solution was then applied to the RNase 
affinity column prepared by coupling N’-(6-aminohexyb-cytidine 
2’(3’)-monophosphoric acid to activated CH-Sepharose 4B (Phar- 
macia) according to the procedure of Scofield et ~l.~RNase was applied 
at a level of 4 to 5 mg/ml of column volume, and was quantitatively 
adsorbed to the column under these conditions. The column was 
washed with 3 to 4 bed volumes of 0.2 M sodium acetate, pH 5.2, and 
then eluted with 4 M NaCl in the same buffer. More than 98% of the 
RNase was recovered in the eluate, resulting typically (see Fig. 1) in an 
8 to 12-fold purification. At this point the RNase was approximately 25 
to 30% pure. Elution of the affinity column with a gradient of NaCl in 
acetate buffer did not yield a significant improvement in purification. 
RNase-containing fractions were pooled and adjusted to pH 3.5 with 
4 M HCl (7). After 1 h the mixture was centrifuged for 10 min at 12,000 
x g; the precipitate was washed with 5 volumes of 0.2 M acetic acid and 
discarded. The pH 3.5 precipitation usually resulted in only about a 
20% increase in purity with 90 to 95% yield. This step was included in 
the purification scheme, however, because it removed materials which 
otherwise precipitated during the subsequent dialysis and which 
tended to co-precipitate significant amounts of RNase. 
The pH 3.5 supernatant and the acetic acid wash were pooled, and 
dialyzed in the Bio-Fiber device against 0.01 M Tris.HCl, pH 7.0. The 
progress of the dialysis was followed by monitoring the electrical 
conductivity of the dialysate. DFP was added to the dialysand (final 
concentration, 1 mM), and, if necessary, the pH was adjusted to 7.0 
with a few drops of 1 M Tris base. In order to separate the RNase 
isozymes this solution was chromatographed on CM-cellulose (-500 
mg RNase on a 2 x 12 cm column), using a l-liter gradient of 0 to 0.15 M 
NaCl in 0.01 M Tris.HCl, pH 7.0. The elution profile of enzymatic 
activity on the CM-cellulose column was essentially identical to that 
shown in Ref. 7. Based on this elution profile the isozyme composition 
of the pancreatic juice was found to be 94% RNase A, 5% RNase B, 
0.7% RNase C, and 0.5% RNase D. 
The RNase-containing fractions corresponding to RNase B, and 
C + D were pooled from several column runs for further purification. 
Only RNases B, C, and D were purified from pancreatic juice. The 
fraction corresponding to RNase A was not processed further. The 
RNase A used as the enzyme standard and for injection experiments 
was the repurified commercial RNase A (Sigma type IA). 
To remove contaminating RNase A, the pooled RNase B peak was 
chromatographed on a column of Con A-agarose (Sigma). The RNase 
A passed through the column unretarded while RNase B was bound 
selectively (cf. Fig. 2a), and was eluted with 10% a-methyl-o- 
glucopyranoside. The column capacity was approximately 1.3 mg of 
RNase B/ml of gel volume of a Con A-agarose gel rated at 3.7 mg of 
3R. E. Scofield, R. P. Werner, and F. Wold, submitted for 
publication. 
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Circulating Half-life of RNases A, B, C, and D 
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FIG. 2. Chromatography of RNase isozymes on Con A-agarose. a, 
samples of 50 pg of the purified RNase isozymes were dissolved in 250 
~1 of 0.1 N Tris.HCl, pH 7.4, containing 1 M NaCl, 1 mM CaCl,, MgCl,, 
and MnCl,, and applied to a l-ml Con A-agarose column prepared in 
a disposable pipette. The column was eluted at the rate of 1 ml (1 bed 
volume) per 10 min, and l-ml fractions were collected. After 40 column 
volumes of the starting buffer, the column was eluted with 10% 
a-methyl-n-glucopyranoside in the same buffer. Elution profiles for 
RNases C and D varied with the amount of enzyme and rate of elution, 
but complete elution of these isozymes required 10 to 20 volumes of 
buffer. b, 100 mg of commercial RNase B (Sigma type XII-B) was 
dissolved in 10 ml of above buffer, and applied to a 15-ml (2 x 5 cm) 
Con A-agarose column. Fractions of 5 ml were collected; the arrow 
marks the beginning of elution with 10% or-methyl-n-glucopyranoside. 
Recovery was greater than 98%. On five separate applications 19 to 
21% of RNase activity was eluted by a-methyl-n-glucopyranoside. 
yeast mannan/ml. The RNase B pool from the lectin column was 
finally rechromatographed on the RNase affinity column as described 
previously. The pooled RNase C + D peak from the CM-cellulose 
column was also rechromatographed on the RNase affinity column. 
RNase C and D isozymes were then separated by chromatography on 
CM-cellulose in a l-liter gradient of 0.02 to 0.075 M NaCl in 0.01 Tris. 
HCl, pH 7.0. RNase C was further purified by isolation of the fraction 
retarded on Con A-agarose (Fig. Za). 
Since the commercial product was a more convenient source of the 
RNase B isozyme, Sigma RNase B (type XII-B) was purified by 
chromatography on Con A-agarose as shown in Fig. 26. The fraction 
which was bound by the lectin column and was eluted by a-methyl-n- 
glucopyranoside, accounted for about 20% of the commercial RNase B 
applied to the column, and was termed RNase Be. The remaining 80% 
of the commercial RNase B was eluted in the void volume of the 
column, and did not contain carbohydrate. The heterogeneity of the 
commercial RNase B, and its separation into two components by 
chromatography on Con A-agarose is verified in the disc gel electropho- 
resis patterns shown in Fig. 3~. 
Glycosidase Dzgestzon of RNase B”-Jack bean a-mannosidase, 
kindly provided by Dr. Gary Nelsestuen (University of Minnesota), had 
a specific activity of 30 rmol of p-nitrophenyl-cu-nmannopyranoside 
hydrolyzed per min at 37” per mg of protein. This enzyme had no de- 
tectable @-N:acetylglucosaminidase or 6-mannosidase (<O.Ol%) ac- 
tivity using p-nitrophenylglycosides as substrates. a-Mannosidase 
(0.3 unit) was added to 12.5 mg of RNase B’ in 5 ml of 0.1 N sodium 
acetate, pH 5.0, containing 1 mM ZnSO, (37’). An additional 0.3 unit of 
cu-mannosidase were added at 12 and 24 h. Aliquots (0.1 ml) were re- 
moved at various times, and assayed for mannose released by a 
coupled hexokinase/pyruvate kinase/lactate dehydrogenase system, 
according to Tarentino et al. (18). The mannose release leveled off af- 
ter 36 h, at which time a total of 3.1 mol of mannose had been removed 
FIG. 3. Polyacrylamide disc gel electrophoresis of RNase isozymes. 
Protein samples (15 to 20 fig) were electrophoresed as described under 
“Materials and Methods.” a, Lane I, RNase A; 2, Sigma type XII-B 
RNase B, showing approximately 4:l ratio of two components; 3, the 
component which is not retarded on Con A-agarose; 4, RNase B’, the 
component eluted from Con A-agarose with cY-methyl-n-glucopyrano- 
side; 5, mixture of equal amounts of each component. b, Lane I, RNase 
A; 2, RNase Be; 3, RNase B’; 4, RNase B; 5, RNase C; 6, RNase D; 7, a 
‘mixture of equal amounts of RNases A, B, C, and D. 
TABLE I 
Carbohydrate composition of ribonuclease isozymes 
For comparable data. see Ref. 7. 
Ribonuclease 
lsozyme A B’ B” B C D 
Glucosamine 0 
Mannose 0 
Galactose 0 
Sialic acid 0 
Fucose 0 
mol carbohydratelmol protein 
1.9 1.8 2.0 4.1 
4.7 1.0 4.3 2.6 
0 0 Tr” 2.0 
0 0 0 2.2 
Tr 0 Tr 1.0 
3.9 
2.9 
1.9 
4.0 
1.1 
cI Tr, trace. 
per mol of RNase B’. At 36 h a sample of the digestion mixture was ap- 
plied to the carbohydrate analyzer, and 3.0 mol of free mannose were 
detected per mol of RNase Be. The product of this ol-mannosidase 
digestion of RNase B’ was isolated by Sephadex G-75 chromatography 
and is referred to as RNase B’. Carbohydrate analyses indicated that 
RNase Bx contained 2 N-acetylglucosamine and 1 mannose residue. 
Based on the structural analysis of Sukeno et al. (19), the residual 
mannose in &linked to an N-acetylglucosamine residue, thus explain- 
ing its resistance to Lu-mannosidase. 
Characterization of RNase Isozymes-Table I shows the carbohy- 
drate composition of the RNase isozymes used in this study. These 
data are in good agreement with those previously published by 
Plummer and Hirs (6, 7). The homogeneity of the isozymes is 
supported by the electrophoretic patterns shown in Fig. 3b in which 
each isozyme yields a single band of staining material with a distinct 
electrophoretic mobility. RNase B, prepared from pancreatic juice, 
and RNase B’, prepared from the commercial product, behave 
identically on disc gel electrophoresis, consistent with the similarity in 
their carbohydrate composition. When chromatographed on Sephadex 
G-75 each isozyme yielded a single peak of protein and enzymatic 
activity, eluting at a volume corresponding to the monomeric form of 
the enzyme; there was no evidence of aggregation. The relative specific 
activity of the various isozymes, using cytidine 2’:3’-phosphate as 
substrate, was: A = 100, B = 96, Be = 96, B’ = 93, C = 94, D = 98. 
Using RNA as substrate, the relative specific activities were: A = 100, 
B = 84, B’ = 78, B” = 80, C = 78, D = 77. From a comparison of the 
relative specific activities using the two different substrates, it appears 
that the oligosaccharide in the glycoprotein isozymes causes a slight 
inhibition of the activity of RNase toward the macromolecular RNA 
substrate. 
Preparation and Sizing of Fluorescein-labeled Dextrun-Dextran 
T-10 (Sigma) was reacted with fluorescein isothiocyanate according to 
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Circulating Half-life of RNases A, B, C, and D 6019 
FRACTION NUMBER 
FIG. 4. Molecular sizing of fluorescein-labeled dextran, RNase, and 
inulin. a, fluorescein/dextran (100 mg) was dissolved in 1 ml of 0.2 M 
ammonium acetate and chromatographed on a column (1 x 35 cm) of 
Sephadex G-75. Fractions of 0.5 ml were collected. Aliquots were 
assayed for anthrone reactivity (21), and fluorescence at 518 nm 
(excitation 493 nm) on a Hitachi Perkin-Elmer MPF-2A fluorescence 
the method of deBelder and Granath (20), using dibutyltin dilaurate 
(Ventron/Alfa) as catalyst. The product was washed three times by 
precipitation with ethanol, then dissolved in distilled water (5% w/v) 
and dialyzed overnight against 100 volumes of distilled water. The 
dialysand was lyophilized, redissolved in 0.2 M ammonium acetate (5% 
w/v), and chromatographed on a calibrated Sephadex G-75 column in 
the same buffer (Fig. 4a). Fractions 40 to 43, corresponding to the 
elution volume of RNase A, were pooled and lyophilized. A mixture of 
RNase A and the sized dextran derivative was chromatographed on the 
same G-75 column to show that the collected fraction of dextran was 
similar in molecular size to RNase A (Fig. 46). In addition, [“Clinulin 
(New England Nuclear, Inulin-carboxyl, [carboxyl-“Clinulin, 19.3 
mCi/g), A4, = 5500, was also chromatographed in the same column run 
to verify its molecular size and the absence of low molecular weight 
degradation products; the data for the [“Clinulin is shown here since 
the [“Clinulin and fluorescein/dextran are used later in the same 
experiment (Fig. 7). 
Animal Experiments-Experiments were performed using normal or 
nephrectomized male albino rats weighing 300 to 360 g. Bilateral 
nephrectomies were performed under ether anesthesia through a 
midline incision. The renal vein and artery, and the ureter were 
ligated, and the kidneys were excised. The incision was sutured, and 
the animal was allowed to recover for 6 to 12 h. Ribonuclease isozymes 
(500 pg) were injected intracardially in 100 to 500 ~1 of physiological 
saline. Blood samples (75 ~1) were obtained at timed intervals from 
lateral tail veins. The first sample was generally taken at 100 s after 
injection. Blood was collected in heparin-treated capillary pipettes, 
and plasma was separated by centrifugation. Aliquots of plasma (3 ~1) 
were assayed in duplicate for RNase activity. Endogenous activity in 
both normal and nephrectomized rats was 0.6 * 0.2 fig of RNase/ml of 
plasma. 
RESULTS 
RNase A, RNase B, and a 1:l mixture of RNase C and D 
were injected separately into normal rats. The data in Fig. 5 
show that all of the isozymes are rapidly cleared from the 
plasma with half-lives of 2 to 3 min. These results confirm 
previous reports on the rapid clearance of RNase A in the rat 
(22-24), and also establish that the carbohydrate prosthetic 
groups on RNases B, C, and D do not significantly alter the 
rate of clearance of these isozymes in the normal rat. 
The site of RNase clearance has been localized primarily in 
the kidney (22-26), and reflects the major role for this organ in 
the catabolism of proteins of molecular weight lower than 
spectrophotometer. Fractions 40 to 43, corresponding in size to RNase 
A, were pooled. b, co-chromatography of pooled fluorescein/dextran 
(0.1 mg), RNase A (0.1 mg), and [“Clinulin (0.1 pCi) under above 
conditions. Aliquots of each fraction were assayed for fluorescence, 
enzyme activity, and radioactivity. 
IL I I 8 
0 200 400 600 000 
TIME (4 
FIG. 5. Clearance of RNase isozymes from plasma of normal rats. 
RNase isozymes (500 rg) were injected into weight-matched groups of 
two or three rats. Half-lives are calculated from least squares fit 
through all points on lines drawn in figure. a, RNase A, t,,, = 155 s; b, 
RNase Be, t 1,2 = 132 s; c, mixture of RNase C + D (l:l), t,,, = 149 s. 
albumin (27, 28) which can readily permeate the glomerular 
basement membrane. Because the rapid, nonspecific renal 
clearance of RNase could prevent the observation of other 
clearance mechanisms operating specifically on the plasma 
proteins, all subsequent experiments were performed with 
nephrectomized rats. 
Fig. 6 shows the results of injection of RNase A into 
nephrectomized rats. The clearance curve is complex, consist- 
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6020 Circulating Half-life of RNases A, B, C, and D 
2 
0 200 400 600 
TIME (mm) 
FIG. 6. Clearance of RNase A from plasma of nephrectomized rats. 
RNase A (500 rg) was injected into three rats, and half-lives were 
estimated as 528 (O), 537 (A), and 577 (0) min, respectively, from the 
least squares fit through points at times greater than 100 min. 
ing of a rapid, initial decline, followed by a slower first order 
clearance process, as is frequently observed in enzyme injection 
experiments (29, 30). The first phase is generally attributed to 
diffusion and equilibration of the enzyme into extravascular 
compartments, and the second, slower phase results from 
catabolic clearance of the enzyme from the circulation. A least 
squares fit was calculated for the second phase of the decay 
curve, and the slope, b,, and intercept, C,, were calculated. 
The half-life of RNase A, (t,,, = 0.693/b,), was found to be 528, 
537, and 577 min in three injection experiments. 
Several lines of evidence suggest that the initial rapid 
decline in plasma RNase resulted from an equilibration process 
rather than from a selective removal of a unique fraction of the 
injected enzyme. Thus, no heterogeneity was detected in any of 
the RNase samples by ion exchange chromatography on 
CM-cellulose or IRC-50, by gel permeation on Sephadex G-75 
(Fig. 4), or by gel electrophoresis (Fig. 3). In addition, efforts to 
detect a binding protein which might mediate the removal of a 
fraction of the RNase as a complex were unsuccessful. No 
inhibition of RNase activity was observed upon mixing with 
plasma, nor was the elution volume of RNase on Sephadex 
G-75 altered after incubation with plasma. 
In a more direct experiment to establish that the first phase 
in the plasma decay curve resulted from an equilibration 
process, the fluorescein-labeled dextran with approximately 
the same molecular size as RNase (Fig. 4) was injected 
simultaneously with RNase A. As shown in Fig. 7 the kinetics 
of the initial clearance of RNase A and the dextran derivative 
are essentially identical, consistent with the hypothesis that 
molecules of the same size should diffuse at identical rates into 
extravascular compartments. The difference in the kinetics of 
clearance during the second phase can be attributed to 
differential rates of catabolism of the RNase A and dextran. 
Analysis of the decay curves shown in Fig. 7 permits an 
estimate of the relative and absolute sizes of the plasma and 
extravascular compartments. By the process of “curve peeling” 
(29) the decay curves were described by the sum of two 
exponential processes, e.g. 
lRNase] = C,e-bl’ + C,e-b*’ 
where [RNase] is the plasma RNase concentration; and C, and 
C, are the intercepts, and b, and b, the slopes of the rapid and 
slow processes, respectively. According to Sterling (29, 31) the 
intercept, C1, can be considered to represent the hypothetical 
concentration of the substance at zero time after equilibration 
with extravascular space (EVS), and the intercept, C,, to 
FIG. 7. Comparison of clearance kinetics for RNase A, fluorescein-la- 
beled dextran (HZ’C), and [“C]inulin. A mixture of RNase A (500 rg), 
dextran (2 mp), and 1”Clinulin (10 UCi) in 0.4 ml of physiological 
saline was injected into a 350-g nephrectomized rat. Data is shown as 
per cent of 100-s time point which contained 34.4 pg of RNase/ml, and 
1550 cpm of “C per 10 pl. The C, intercept on the inulin curve is higher 
than the RNase and dextran curues, reflecting the more rapid rate of 
inulin (M, - 5500) equilibration into extravascular compartments. 
The C, and C, intercepts for RNase A were at 105 and 23% 
respectively, and for dextran, 109 and 21%. The half-life of RNase A in 
this experiment was 5.6 and 540 min for the first and second phases, 
respectively, and, for fluorescein-labeled dextran, 5.0 and 360 min. 
represent the concentration of a substance that would have 
existed in the plasma volume (Pl) at zero time if no equilibra- 
tion had taken place. Then, the approximate ratio of compart- 
ment sizes can be estimated from the equation: 
Cl EVS _=- 
c, Pl 
Computed in this manner, the ratio of compartment sizes 
(EVS/Pl) for RNase A is 4.6, and for the sized dextran, 5.2 
(data in legend to Fig. 7). From the similarities in the kinetics 
of clearance, and the C,and C, intercepts for the RNase and 
dextran curves, it appears that these molecules are equilibrat- 
ing not only at the same rate but also in the same ratio into 
plasma and extravascular compartments. From the data in this 
and the other experiments (cf. Figs. 6 and 8), the extravascular 
compartment appears to be about 4.5 to 5.5 times as large as 
the plasma compartment for a molecule of the size of RNase A. 
The total volume, VT, into which the injected material is 
distributed can be independently estimated from the quantity 
injected (Q) and the concentration at C, (after equilibration, 
but before clearance), i.e. 
Q - = VT = Pl + EVS. 
C2 
In the experiment in Fig. 7, the injection of 500 pg of RNase 
produced a C, intercept of 7.5 pg of RNase/ml of plasma (cf. 
Fig. 7 legend), which yields a total distribution volume, VT = 
67 ml for RNase A. An independent estimate of VT was 
obtained by simultaneously injecting 10 &i of [“Clinulin, 
resulting in VT = 63 ml for inulin. The estimated VT for 
dextran was 49 ml, but this is probably the least accurate VT 
estimate since serum proteins altered the dextran’s fluores- 
cence and thus introduced uncertainties in the estimates of Q. 
The data obtained with RNase A and [“Clinulin in a 350-g rat, 
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FIG. 8. Clearance of RNases C and D from plasma of nephrectomized 
rats. a, RNase C (500 pg) injections into three rats resulted in estimated 
half-lives of 681 (O), 830 (A), and 862 (0) min. 6, RNase D (500 rg) 
injections yielded half-lives of 839 (0), 859 (A), and 941 (0) min. 
indicate that the extracellular fluid volume is about 16 to 20% 
of the body weight. These estimates are consistent with the 
estimated plasma volume of 3% of the body weight in the rat 
(32) and an extravascular compartment of about 5 times the 
plasma volume. These volumes and ratios may not, however, 
represent the normal physiological situation in the rat since the 
animals used in these experiments had been nephrectomized 6 
to 12 h earlier. 
Having established that the initial rapid clearance of RNase 
from plasma is an equilibration process, our attention was now 
focused on the second, slower phase which represents the 
catabolic clearance of the molecule. Fig. 8, a and 6, shows the 
plasma decay curves for injections of RNases C and D. The 
half-lives for RNase C in three rats were 681, 830, and 862 min, 
and for RNase D in three rats 839, 859, and 941 min. In three 
other preliminary experiments in which a partially purified 
mixture of RNase C and D (pooled C + D peak from first 
CM-cellulose fractionation) were injected, the half-lives of the 
C + D mixture were 691, 787 and 799 min. In all experiments 
the half-lives of the RNase isozymes containing complex 
carbohydrates (C and D) were 25 to 75% longer than the 
half-life of RNase A. The half-lives of RNases C and D were not 
significantly different from one another. 
Fig. 9 shows that, in contrast to RNases A, C, and D, RNase 
B and RNase B” are rapidly cleared from the circulation with a 
half-life of approximately 15 min. At 3 h after the RNase B and 
B’ injections the residual plasma RNase activity was generally 
indistinguishable from endogeneous levels, while levels of 
RNase A, C, and D at this time consistently were at 5 to 10 
times the endogenous activity. 
Since the only difference between RNase B or B’ and the 
other RNase isozymes is the presence of the simple oligosac- 
charide at Asn-34, it is reasonable to propose that this 
oligosaccharide, and specifically its terminal ol-mannosyl resi- 
dues, might be involved in the rapid clearance of RNase B. To 
test this proposal RNase B” was treated with jack bean 
cr-mannosidase (see “Materials and Methods”) resulting in the 
release of all but 1 mannose residue per RNase molecule. The 
background 
0 
0.5 
50 
c 
0 100 150 2c 
TIME (min) 
FIG. 9. Clearance of RNase B and B’ from plasma of nephrectomized 
rats. Two animals were used for each isozyme (500 pg of RNase per 
injection). Black bar at lower left shows the range of background 
activity for these animals. The line with tri = 15 min is a least 
squares fit through all points at less than 60 min, and is drawn as a 
convenient reference only; the slope of the clearance curve appears, in 
fact, to be varying continuously during the experiment. 
20 24 28 - 
-I 
FRACTION NUMBER 
FIG. 10. Chromatography of RNase B’ on Con A-agarose before and 
after a-mannosidase treatment. RNase B” was treated with a-man- 
nosidase as described under “Materials and Methods.” Aliquots (100 
rg) of the original RNase B”, and the product, RNase B’, were 
chromatographed on l-ml columns of Con A-agarose as described in 
Fig. 2a. 
product of the mannosidase digestion, RNase B”, was reiso- 
lated by chromatography on Sephadex G-75. The purified 
RNase B” was no longer bound by concanavalin A (Fig. 10); this 
is consistent with the fact that its a-mannosyl residues, the 
recognition site for binding to concanavalin A, had been 
enzymatically removed. Chemical analysis of RNase B” sug- 
gests that its core trisaccharide (19), Asn-(GlcNAc), B (Man) 1, 
is still intact. 
Fig. 11 depicts the results of injection experiments with 
RNase B”. The rapid clearance characteristic of RNase B” was 
not observed after removal of the a-mannosyl residues of the 
simple oligosaccharide. The half-life of RNase B” in three rats 
was 616,636, and 733 min, an average of about 20% longer than 
that of RNase A. 
DISCUSSION 
Since the several isozymes of RNase differ only in their 
carbohydrate prosthetic group, the differences in the plasma 
half-lives of these isozymes can be attributed to the influence 
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FIG. 11. Clearance of RNase B’ from plasma of nephrectomized rats. 
Three animals were injected with 500 ~cg of RNase B”, resulting in 
estimated half-lives of 616 (A), 636 (0), and 733 (0) min. The kinetics 
of clearance of the original RNase BC is shown (A- - -A) for 
comparison. 
TABLE II 
Plasma half&es of RNase isozymes 
RNase Isozyme Measured half-life 
min 
RNase A 528,537,540,517 
RNase B -15 
RNase B” -15 
RNase B” 616,636,733 
RNase C 681,830,862 
RNase D 839,859,941 
of the specific type of oligosaccharide moiety in the isozyme. 
The findings from the comparison of the half-life of the 
isozymes are summarized in Table II and include two signifi- 
cant, new observations concerning the effect of glycosylation on 
the plasma survival time of a protein. First, in comparison to 
the nonglycosylated protein the attachment of a complex, 
acidic oligosaccharide to the polypeptide chain results in only a 
relatively small (175%) increase in the half-life of RNase in the 
circulation. Secondly, the attachment of a simple, neutral, 
a-mannosyl-terminal oligosaccharide at the same site on the 
same polypeptide chain results in a significant, more than 
30-fold decrease in its half-life in the circulation. 
It seems unlikely that the major biological role for the 
complex oligosaccharides is reflected in the slight increase in 
half-life of RNases C and D as compared to RNase A. Indeed, 
the increase in half-life of RNases C and D might be attributed 
solely to the shift in the isoelectric point (~1) of RNase 
produced by the 2 or 4 sialic acid residues at the end of the 
oligosaccharide chain. Rutter and Wade (33) and Holcenberg 
et al. (34) have shown that the half-life of an enzyme in plasma 
is closely related to its p1. Thus, one would predict that the 
lowered p1 of RNases C and D relative to RNase A would be 
adequate to explain their increased plasma half-life. 
We consequently conclude that the intact complex oligosac- 
charide of the plasma glycoproteins may not directly affect the 
rate of these protein’s catabolism in the circulation relative to 
the corresponding nonglycosylated proteins. However, the 
previous work which has clearly established hepatic removal of 
asialo-(p-galactosyl-terminal)glycoproteins from the mamma- 
lian circulation (2), and asialo-agalacto-(&N-acetylglucosami- 
nyl-terminal)glycoproteins from the avian circulation (3), 
leaves little doubt that the partially degraded, or incompletely 
synthesized oligosaccharide carries important messages. The 
messages in the cases studied to date appear to function in 
restricting the site of catabolism of certain glycoproteins to the 
liver. These proteins may normally be present in only trace 
amounts in plasma, and Burger et al. (35, 36) have, for 
example, presented evidence which indicates that the catabo- 
lism of transcobalamin II specifically in the liver via the 
Ashwell-Morel1 pathway might be involved in the regulation of 
vitamin Blz homeostasis. At this stage it appears, therefore, 
that the intact complex carbohydrate chain, which may not 
itself affect the half-life of circulating glycoproteins, carries a 
potential tissue-directing signal, which must be uncovered by 
alteration in its covalent structure before it can be read. 
The results presented in this paper demonstrate that an 
additional “hidden” signal in the RNase isozymes is specifi- 
cally expressed by exposed, nonreducing terminal a-mannosyl 
residues. When RNase A has been biologically modified by the 
attachment of a simple oligosaccharide to form RNase B, its 
half-life in the circulation was found to be reduced by about 
30-fold. This change could be reversed by enzymatic removal of 
the a-mannosyl residues of RNase B, and the product, RNase 
B’, returned to a half-life comparable to that of RNase A. These 
observations clearly support the existence of a carbohydrate- 
specific clearance process in the rat, which recognizes glyco- 
proteins with terminal a-mannosyl residues. 
The mechanism of this a-mannosyl-dependent clearance 
process has not yet been determined, but the existence of a 
plasma-binding protein which could mediate the specific 
clearance of RNase B has been excluded. The presence of such 
a protein was considered unlikely in view of the rapid and 
essentially identical clearance rates for all the RNase isozymes 
through the kidney of the normal (un-nephrectomized) rat 
(Fig. 5). In addition, as mentioned previously, when RNase B 
was mixed with serum or plasma, a binding protein was not 
detectable through any inhibition of RNase activity on its high 
molecular weight (yeast RNA) substrate; nor was the elution 
volume of RNase B on Sephadex G-75 altered upon mixing 
with serum or plasma. Thus it seems that, by analogy to the 
clearance process described by Ashwell and Morel1 (2), the 
clearance of RNase B probably occurs by way of a membrane- 
binding protein, specific for the a-mannosyl residues of the 
simple oligosaccharide; and the list of carbohydrate-binding 
proteins involved in these recognition processes in vertebrates 
must be expanded from currently established fl-galactosyl- (2) 
and /3-N-acetylglucosaminyl-binding proteins (3) to include an 
a-mannosyl-binding protein as well. 
The physiological function of this protein clearance mecha- 
nism is not known. It is interesting, however, to note that the 
simple oligosaccharide, containing only mannose and N- 
acetylglucosamine, is not a common component of plasma 
glycoproteins. It is found in IgM (37) and IgE (38), and possibly 
in IgA (39-41), but is apparently not present in IgG (42), 
al-acid glycoprotein (43), a,-antitrypsin (44), ceruloplasmin 
(45), transferrin (46), or fetuin (47). Detailed information on 
oligosaccharide structures is unfortunately not available for 
the majority of the plasma proteins (e.g. ligand-binding 
proteins, clotting factors, and complement proteins) so that a 
true estimate of the frequency or distribution of the simple 
oligosaccharide structures cannot be made. For the immuno- 
globulins, IgM and IgE, the simple oligosaccharide may 
perform an important function. The fact that the immunoglob- 
ulins are relatively stable proteins in plasma suggests that-the 
simple oligosaccharides in these proteins are normally steri- 
tally protected from the sensing mechanism which rapidly 
clears RNase B. (Perhaps the steric restriction explains why the 
complex oligosaccharide was not synthesized on that site.) It is 
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possible, then, that upon interaction with antigen, a conforma- 
tional change in the antibody molecule could present the 
simple oligosaccharide to the environment, resulting in the 
clearance of the antibody.antigen complex. Such a process 
might be physiologically important, especially under condi- 
tions of antigen or antibody excess when macromolecular 
aggregates may not be formed, e.g. during the initial or final 
stages of an immune response. It is perhaps not a coincidence 
that, in both IgM and IgE, the simple oligosaccharides are 
located at homologous sites in the Fc region of the heavy chain, 
the region which is known to be involved in the disposition of 
antibody subsequent to antigen binding. Other ligand-binding 
proteins in plasma, which are rapidly cleared following com- 
plex formation, may also have simple oligosaccharides. Thus, 
for example hemoglobin. haptoglobin (48, 49), heme. hemo- 
pexin (49), and protease.a,-macroglobulin (50, 51) complexes 
might be cleared in a manner similar to that proposed above 
for some antigen.antibody complexes. 
The lysosomal glycosidases comprise a group of glyco- 
proteins which are known to be rapidly cleared from the 
circulation following intravenous injection (52254). And, while 
the details of the carbohydrate structures of these enzymes are 
not known, the limited information on their binding to 
insolubilized concanavalin A (55, 56) and their high mannose 
content (57, 58) suggest that the removal of these enzymes 
from the circulation may be mediated by the a-mannoside- 
dependent clearance process which we have described for 
RNase B. In this respect, Stahl et al. (54) have reported that 
the clearance of fi-glucuronidase is apparently not mediated by 
liver receptors for asialo-(galactosyl-terminal)glycoproteins, 
since asialofetuin and asialo-orosomucoid failed to competi- 
tively inhibit the clearance of P-glucuronidase from the rat 
circulation. Thus it appears that, among other possibilities, the 
cY-mannoside-dependent clearance process may be involved in 
regulating (i.e. limiting) the level of lysosomal enzymes in the 
circulation, or may participate in the transport of lysosomal 
enzymes or other proteins between cells and organs within the 
body. 
In the above discussion, it has been tacitly assumed that the 
process in which the a-mannosyl residues of RNase B are 
recognized is directly exposed to the plasma compartment, and 
that the removal of RNase B takes place directly from that 
compartment. However, this is clearly not a necessary assump- 
tion in view of the rapid equilibration of the RNase into the 
extravascular compartment. Indeed, the mannose recognition 
and removal could occur equally well in either or both compart- 
ments. Future studies must be directed at establishing the or- 
gan specificity, the compartment location, and the physiologi- 
cal function of this clearance process. 
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